vasoactive intestinal peptide pancreas peptide - Vasoactive intestinal peptidetest results Vasoactive intestinal peptide (VIP) attenuates experimental acute pancreatitis Understanding Vasoactive Intestinal Peptide and Its Role in the Pancreas

VIPoma vs carcinoid Vasoactive intestinal peptide (VIP) is a fascinating peptide hormone with a wide range of physiological functions throughout the body, including significant roles within the pancreas. While it is produced in many tissues of vertebrates including the gut, pancreas, and nervous system, its presence and activity in the pancreatic tissue are of particular interest to researchers and clinicians. Understanding the function of vasoactive intestinal peptide in the pancreas is crucial for comprehending normal physiological processes and for diagnosing and treating certain rare conditionsVasoactive Intestinal Peptide: A Secretin-Like Partial ....

The pancreas is an organ that plays a dual role in digestion and hormone production. It secretes digestive enzymes into the small intestine and also produces hormones like insulin and glucagon that regulate blood sugar. Vasoactive intestinal peptide (VIP) has been shown to exert effects on endocrine and exocrine pancreatic secretion. Specifically, research indicates that VIP appears to be responsible for atropine-resistant, neurally mediated pancreatic ductal bicarbonate secretion. This means that VIP plays a role in stimulating the release of bicarbonate from the pancreatic ducts, which helps neutralize stomach acid in the small intestine, facilitating digestion. Studies have demonstrated that vasoactive intestinal peptide stimulates in vitro pancreatic ductal bicarbonate secretion, highlighting its direct impact on exocrine function.Vasoactive intestinal peptide reduces oxidative stress in ...

Beyond its role in exocrine secretion, VIP also influences endocrine functions of the pancreasVasoactive intestinal polypeptide (VIP) in the pig pancreas. While VIP has been shown to stimulate insulin release from the normal pancreas, its precise role on glucagon secretion is still under investigation. This dual action suggests a complex regulatory mechanism involving vasoactive intestinal peptide in glucose homeostasis.

However, the significance of vasoactive intestinal peptide in the pancreas extends to pathological conditions, most notably VIPoma.作者：ZC Wu·1979·被引用次数：79—Two gastrointestinal peptides,vasoactive intestinal polypeptide (VIP) and pancreatic polypeptide, suspected of being associated with symptoms of WDHA syndrome ... A VIPoma is a rare type of pancreatic neuroendocrine tumor that arises from the islet cells of the pancreas. These tumors are characterized by the excessive production and secretion of vasoactive intestinal peptide. This overproduction leads to a condition known as Verner-Morrison syndrome, often associated with profuse diarrhea, hence its description as a vasoactive intestinal peptide secreting tumor (VIPoma). In fact, VIPoma causes cells in the pancreas to produce a high level of this hormone, which then increases secretions from the digestive system.

The clinical presentation of a VIPoma is often dramatic, with severe watery secretory diarrhea being a hallmark symptom. This is directly linked to the actions of vasoactive intestinal peptide, which triggers cyclic adenosine monophosphate (cAMP) production, vasodilation, and other physiological responses that contribute to fluid and electrolyte imbalancesVasoactive Intestinal Peptide (VIP) Secreting Neuroendocrine Tumor ·Most Commonly Arise from Islet Cells of the Pancreas(75-90%) · *See Pancreatic .... The term Verner Morrison syndrome is often used interchangeably with VIPoma, underscoring the direct connection between the syndrome and the hormone.

Diagnosing a VIPoma typically involves measuring vasoactive intestinal peptide levels in the blood.Sporadic pancreatic vasoactive intestinal peptide- ... A vasoactive intestinal peptide test can help confirm the diagnosis.VIPoma - StatPearls - NCBI Bookshelf - NIH The VIPomapancreas is the most common location for these tumors, though they can occasionally occur elsewhere. Understanding the VIPoma location in pancreas is vital for surgical planning and treatment.

Treatment for VIPoma focuses on managing the symptoms and removing the tumorFlushing and Diarrhea Associated With Vasoactive .... Surgical resection is the primary curative option.A very rare tumor that usually forms in the islet cells of thepancreas and makes the hormone vasoactive intestinal peptide (VIP). In cases where surgery is not feasible, or for metastatic disease, medical management aims to control the diarrhea and electrolyte disturbances. Research is also exploring novel therapeutic strategies, such as targeting vasoactive intestinal peptide-mediated signaling, which has shown promise in enhancing responses to other treatments in certain pancreatic cancers.

It is important to differentiate VIPoma from other neuroendocrine tumors, such as carcinoid tumors, which can present with similar gastrointestinal symptoms but are caused by the overproduction of different hormones.Effects of vasoactive intestinal peptide and pancreatic ... The specific diagnosis of VIPoma vs carcinoid relies on identifying the underlying secreted hormone.Sporadic pancreatic vasoactive intestinal peptide- ...

In summary, vasoactive intestinal peptide (VIP) is a vital hormone with multifaceted roles in the pancreas, influencing both exocrine and endocrine functions. While essential for normal physiology, its dysregulation, particularly through the development of very rare pancreatic neuroendocrine tumors (PNETs) like VIPoma, can lead to severe clinical manifestationsVasoactive intestinal peptide (VIP) stimulates in vitro .... Continued research into the intricate mechanisms of vasoactive intestinal peptide and its associated tumors is crucial for improving patient outcomes. The presence of VIP-immunoreactive cells have been detected in the pancreas, particularly in the islets, further solidifies its integral role within this organ.Vasoactive intestinal peptide (VIP) stimulates in vitro ... It is worth noting that vasoactive intestinal peptide (VIP) also attenuates experimental acute pancreatitis, suggesting a protective role in certain inflammatory conditions of the pancreas.